胸腺嘧啶核苷磷酸化酶(TP)多克隆抗體
Polyclonal Antibody to Thymidine Phosphorylase (TP)
TYMP; PDECGF; ECGF1; MNGIE; TP; HPD-ECGF; TdRPase; Platelet-Derived Endothelial Cell Growth Factor; Gliostatin
- 編號PAA948Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4, 含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 569 ¥ 1327 ¥ 1896 ¥ 4740 ¥ 18960
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Sample: Porcine Colon Tissue Primary Ab: 10μg/ml Rabbit Anti-Human TP Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Sample: Porcine Stomach Tissue
Primary Ab: 10μg/ml Rabbit Anti-Human TP Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant TP, Human.
-
Western Blot; Sample: Lane1: Hela cell; Lane2: MCF7 cell; Lane3: Human Lung lysate
Primary Ab: 2μg/mL Rabbit Anti-Human TP Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Samples: Lane1: Human Platelet lysate; Lane2: THP1 cell lysate;
Primary Ab: 0.1μg/ml Rabbit Anti-Human TP Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對TP的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別TP。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA948Hu01 | 胸腺嘧啶核苷磷酸化酶(TP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA948Hu01 | 胸腺嘧啶核苷磷酸化酶(TP)多克隆抗體 | WB; IHC; ICC; IP. |
| MAA948Hu22 | 胸腺嘧啶核苷磷酸化酶(TP)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA948Hu | 胸腺嘧啶核苷磷酸化酶(TP)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA948Hu | 胸腺嘧啶核苷磷酸化酶(TP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA948Hu01 | 胸腺嘧啶核苷磷酸化酶(TP)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Eur J Obstet Gynecol Reprod Biol. | Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis [Pubmed: 24188612] |
| PLoS One. | Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy [Pubmed:24802030] |
| BMC Clinical Pathology | Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer [Pubmed:24936150] |
| Oncotarget | Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells [Pubmed:29707135] |
| Clinica?Chimica?Acta | Prognostic significance of serum translocator protein in patients with traumatic brain injury [Pubmed: 30385279] |
| JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | Usefulness of postoperative serum translocator protein as a predictive marker for delirium after breast cancer surgery in elderly women [Pubmed: 32529881] |
| Bioengineering & Translational Medicine | Targeting thymidine phosphorylase as a potential therapy for bone loss associated periprosthetic osteolysis [] |
